Clinical Trial Update: Effectiveness of Entresto (Sacubitril/Valsartan) in Japanese Patients With Hypertension

View source ↗

Summary

This trial update reports on the effectiveness of Entresto (sacubitril/valsartan) in Japanese patients with essential hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Entresto (sacubitril/valsartan)

Snippet

Sponsor: Novartis | Conditions: Essential Hypertension | Status: ACTIVE_NOT_RECRUITING